Federal Health Agencies Call to Pause Johnson & Johnson Vaccine

Headline Roundup April 13th, 2021

The FDA and CDC have requested a pause in the use of Johnson & Johnson’s single-dose COVID-19
vaccine after six U.S. recipients developed a rare disorder involving blood clots within nearly two weeks of vaccination, officials said on Tuesday. The officials said the clots appear to be rare, but people who develop severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination should contact their doctor.

More than 6.8 million doses of the Johnson & Johnson vaccine have been administered in the U.S., the vast majority with no or mild side effects.

Federal Health Agencies Call to Pause Johnson & Johnson Vaccine

From the Left
13320
coronavirus, coronavirus vaccine, Johnson & Johnson

Federal health officials on Tuesday called for a pause in the use of the Johnson & Johnson coronavirus vaccine, saying they are reviewing reports of six U.S. cases of a rare and severe type of blood clot in people after receiving the vaccine.

All six cases occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination, according to a statement issued by the Food and Drug Administration and the Centers for Disease Control and Prevention.

The CDC will hold a meeting...

Read full story
Some content from this outlet may be limited or behind a paywall.
From the Center
13320
coronavirus, coronavirus vaccine, Johnson & Johnson

The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48.

The...

Read full story
From the Right
13320

Federal health agencies requested an abrupt pause in the use of Johnson & Johnson’s single-dose coronavirus vaccine after six U.S. recipients developed a rare disorder involving blood clots within nearly two weeks of vaccination, officials said on Tuesday.

The Food and Drug Administration, along with the Centers for Disease Control and Prevention, announced the news on Twitter and will reportedly stop distributing the vaccine at federal sites and encourage states to do so while an investigation is underway for safety issues.

“Today FDA and @CDCgov issued a statement regarding the...

Read full story

AllSides Talks

Learn more about AllSides Talks